Navigation Links
Astaxanthin Stability Breakthrough Achieved by Valensa
Date:8/19/2009

ORLANDO, Fla., Aug. 19 /PRNewswire/ -- Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life. Published reports by other astaxanthin producers indicate ranges of 1 - 2 years under refrigeration as the existing state-of-the-art for astaxanthin stability. Effective immediately, Valensa has raised its Zanthin(R) brand astaxanthin oleoresin stability recommendation to 4 years at 20 degrees C. The greater stability profile of Zanthin(R) astaxanthin will allow formulators of nutraceutical products to use smaller safety margins (overage) to assure consumers of efficacy in products on a store shelf, which can lead to cost savings.

According to Rudi E. Moerck, President & CEO of Valensa International, it is incumbent on producers of nutraceutical ingredients to manage the stability issues of their extracted products to assure safety and quality. "Anytime you extract oils or oleoresins from natural materials, you are faced with stability issues relating to oxidative degradation. At Valensa, we have developed a considerable body of expertise in addressing the stability of our extracted products, continually developing new extraction methodologies and developing customized stabilization packages that are natural and protect our products and the people who use them," he said. "The data in our just concluded study are a confirmation of why our customers put their trust in Zanthin(R) natural astaxanthin as the best and most stable astaxanthin ingredient on the market today. Essentially, we have been able to eliminate stability concerns and create a new level of astaxanthin shelf-life for our customers," he added. Moerck went on to point out that the company's position as a fully integrated supplier with chain of custody over raw materials growing and harvesting through the extraction process is the source for overall quality for its Zanthin(R) natural astaxanthin and contributes to the company's ability to manage shelf-life issues. Valensa now recommends a 5% safety margin, or "overage," for its astaxanthin as compared to the 10% the industry typically uses.

ZANTHIN(R) - A natural, high efficacy extract with proven quality

Valensa International is the world's leading manufacturer of finished form natural astaxanthin extract. It was the first company to have finished form material approved for use by regulatory agencies in both the United States and Europe. Valensa employs its proprietary DeepExtract(R) supercritical CO2 process to create the best quality materials and its O2B(R) Peroxidation Blocker stabilization technology to ensure long-term stability and efficacy for the consumer. The company employs dedicated organic certified facilities for the extraction of astaxanthin to ensure quality and avoid the potential for contamination by solvents or allergens that can occur when an astaxanthin extractor is also producing other products -- such as peanuts or shell-fish-based materials -- in the same equipment. Scientific studies of stability chemistry with extracted plant-derived oleoresins have allowed Valensa to move beyond ingredients such as safflower oil -- a diluent widely used in the industry and which that actually increases oxidative degradation -- to custom-tailored stabilization packages designed for the product in question.

For information on Zanthin(R) Natural Astaxanthin, please contact Valensa directly.

    For further information, contact:

    Rudi Moerck, President & CEO
    Voice: 352-357-2004
    Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE Valensa International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
2. Valensa Completes Second Expansion of Astaxanthin Capacity
3. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
4. Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector
5. Effect of mutant p53 stability on tumorigenesis and drug design
6. Unique skeletal muscle design contributes to spine stability
7. National Front Line Caregiver Group Urges Senate Leaders to Support Grassley Amendment Protecting Seniors Care, Assuring Stability of Nations Long Term Care Workforce
8. Studies evaluate the anatomy and stability of ACL reconstruction with different techniques
9. External focus improves postural stability in patients with Parkinsons disease
10. Covance Expands Analytical and Stability Service Capacity in North America
11. Morehead Presents Webinar on Preventing Physician Disloyalty: Building Stability and Trust with 'At-Risk' Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... Hospital M&A activity slowed in the second quarter of ... acquisitions rose to 23 in the second quarter, up 15% from the 20 publicly ... announced deals in the year-ago second quarter. Only four of the transactions disclosed a ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... anterior cruciate ligament (ACL) offer patients improved quality of life five years after ... Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed patients ...
(Date:7/20/2017)... 2017 (PRWEB) , ... July ... ... global provider of enterprise-grade IT operations analytics and application performance monitoring (APM) ... of world’s largest healthcare services providers. , According to Peter Ohrenberger, sales ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network ... Horine Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list of ... with Dr. Russell Horine serving as the clinic director and his son Dr. Lee ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. , ... UTHR ) announced today that it will ... market opens on Thursday, July 27, 2017. ... teleconference on Thursday, July 27, 2017, at 9:00 a.m. ... with international callers dialing 1-970-315-0533.  A rebroadcast of the ...
(Date:7/19/2017)... , July 19, 2017  Mako Medical Laboratories partnered ... the Military Family Assistance Fund (MFA) to bring 140 ... to visit with their families one last time before ... coordinate the travel and logistics needed for these soldiers. ... soldiers and their families. We just wish we could ...
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
Breaking Medicine Technology: